AvePoint Q4 Earnings and Revenues Beat Estimates, Sales Rise Y/Y

AvePoint AVPT reported fourth-quarter 2025 non-GAAP earnings of 10 cents per share, which surpassed the Zacks Consensus Estimate by 11.11% and increased 350% year over year.

AvePoint revenues climbed 29% year over year to $114.7 million, beating the Zacks Consensus Estimate by 3.22%.

AVPT shares have soared 2.79% at the time of writing this article.

Top-Line Details of AVPT

SaaS revenues (77.5% of total revenues) increased 37.1% year over year to $88.9 million. Term license and support revenues (8.8% of total revenues) rose 7.4% to $10.1 million, whereas Services revenues (12.8% of total revenues) grew 19.8% to $14.7 million. Maintenance revenues (0.9% of total revenues) decreased 63.4% to $1 million.
 

                     AvePoint, Inc. Price, Consensus and EPS Surprise

AvePoint, Inc. price-consensus-eps-surprise-chart | AvePoint, Inc. Quote

Annual recurring revenues (ARR) climbed 27% year over year or 26% on a constant currency basis to $416.8 million.

AVPT’s Operating Details

In the fourth quarter, AvePoint’s non-GAAP gross margin contracted 130 basis points year over year to 74.2%

Research and development expenses, as a percentage of revenues, decreased 210 bps year over year to 10%. Sales and marketing expenses, as a percentage of revenues, fell 250 bps year over year to 31.2%.

General and administrative expenses, as a percentage of revenues, declined 40 bps year over year to 13.1%.

The operating margin expanded 370 bps on a year-over-year basis to 19.9%

AVPT’s Balance Sheet & Cash Flow

As of Dec. 31, 2025, cash, cash equivalents and short-term investments totaled $481.1 million, up from $471.6 million at the end of the third quarter of 2025.

During 2025, cash generated through operating activities was $85.3 million and free cash flow was $81.6 million.

AvePoint Initiates Q126 and FY26 Outlook

For the first quarter of 2026, the company expects total revenues between $115 million and $117 million, implying 25% year-over-year growth at the midpoint. On a constant currency basis, the company anticipates revenue growth of 20% at the midpoint.

Non-GAAP operating income is estimated between $19.5 million and $20.5 million.

For 2026, the company expects total revenues between $509.4 million and $517.4 million, suggesting 22% year-over-year growth at the midpoint. On a constant currency basis, the company projects revenue growth of 20% at the midpoint.

The company anticipates total ARR between $525.1 million and $531.1 million, indicating 27% year-over-year growth at the midpoint. On a constant currency basis, ARR growth is expected to be 26% at the midpoint.

Non-GAAP operating income is estimated between $92.6 million and $96.6 million.

Zacks Rank and Stocks to Consider

Currently, AVPT has a Zacks Rank #4 (Sell).

Micron Technology MU, MongoDB MDB, and Adobe ADBE are some better-ranked stocks that investors can consider in the broader Zacks Computer and Technology sector.

Micron Technology shares have gained 343.8% in the past 12 months. This Zacks Rank #1 (Strong Buy) company is scheduled to release second-quarter 2026 results on March 18. You can see the complete list of today’s Zacks #1 Rank stocks here.

MongoDB shares have returned 25.8% in the past 12 months. MDB is scheduled to release its fourth-quarter 2026 results on March 2. The company currently sports a Zacks Rank #1.  
 
Adobe shares have lost 40.8% in the past 12 months. ADBE is set to report its first-quarter fiscal 2026 results on March 12. The company currently carries a Zacks Rank #3 (Hold).

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research